Suppr超能文献

维持性血液透析的终末期肾病患者中透析器传统一次性使用与机械复用的总直接成本比较:一项单中心研究。

Comparison of total direct cost of conventional single use and mechanical reuse of dialyzers in patients of end-stage renal disease on maintenance hemodialysis: A single center study.

作者信息

Qureshi Ruqaya, Dhrolia Murtaza F, Nasir Kiran, Imtiaz Salman, Ahmad Aasim

机构信息

The Kidney Centre Post Graduate Training Institute, Karachi, Pakistan.

出版信息

Saudi J Kidney Dis Transpl. 2016 Jul-Aug;27(4):774-80. doi: 10.4103/1319-2442.185242.

Abstract

Reusing dialyzers is almost universal in developing countries to reduce the cost of hemodialysis (HD). Economic benefits of dialyzer reuse, when estimated only on the basis of the dialyzer and its consumables are very significant and attractive. In this study, we compared the cost of mechanical reuse of dialyzer considering all of the direct costs (medications, dialyzer, and its consumables, disinfection fluid, and hospitalization if any) in HD treatment, which if significantly different between single use and reuse, can nullify the obvious cost benefits. A total of 70 adult patients of any gender on maintenance HD at The Kidney Centre Post Graduate Training Institute for more than three months were included. Equal numbers of patients were on single use (Group A) and reuse of dialyzer (Group B). Both groups were compared for total direct costs of HD over a six months period. Average six monthly total direct cost per patient of Group A was significantly high as compared to Group B, the United States Dollar (USD) 1750.67 ± 135.31$ vs. USD 1488.50 ± 132.23$); difference USD 262.18$ (P <0.001). The total cost saving being 14.97% in Group B. Our study shows that dialyzer reuse provides a significant economic benefit and remains a means of reducing the cost of HD.

摘要

在发展中国家,为降低血液透析(HD)成本,复用透析器几乎很普遍。仅基于透析器及其耗材估算的透析器复用经济效益非常显著且有吸引力。在本研究中,我们比较了血液透析治疗中考虑所有直接成本(药物、透析器及其耗材、消毒液以及如有住院费用)的透析器机械复用成本,若单次使用和复用之间存在显著差异,可能会抵消明显的成本效益。纳入了肾脏中心研究生培训学院70名维持性血液透析超过三个月的成年患者,男女不限。单次使用组(A组)和透析器复用组(B组)患者数量相等。比较了两组在六个月期间血液透析的总直接成本。A组患者平均六个月的总直接成本显著高于B组,分别为1750.67美元±135.31美元和1488.50美元±132.23美元;差值为262.18美元(P<0.001)。B组的总成本节约为14.97%。我们的研究表明,透析器复用提供了显著的经济效益,仍然是降低血液透析成本的一种方式。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验